Sun Pharmaceutical Industries et al., 2024-09-12: US label for aminolevulinic acid (Levulan Kerastick) plus blue light: the approved photodynamic indication is actinic keratoses of the face, scalp or upper extremities – a different photosensitizer from methylene blue.
The LEVULAN KERASTICK for topical solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face, scalp, or upper extremities.
Section 1 (Indications and Usage)
Sun Pharmaceutical Industries et al., 2024-09-12: US label for aminolevulinic acid (Levulan Kerastick) plus blue light: the approved photodynamic indication is actinic keratoses of the face, scalp or upper extremities – a different photosensitizer from methylene blue. C8 label record – skin cancer. Record field: the excerpt is the INDICATIONS AND USAGE section of the SPL, not prose in an article; confidence MEDIUM is not needed because the text is verbatim from the label. Country: USA. Approved agent: aminolevulinic acid HCl, topical, blue light (BLU-U). Not methylene blue. Cited to establish which photosensitizer the clinical record for skin actually uses. Study type: regulatory record.
